Immunotherapy in gastric cancers

Rectal cancer in Latin America, screening and surgery

Simplifying molecular subtypes of metastatic gastric cancer

Quality of life results from pembrolizumab vs chemotherapy in gastric or gastroesophageal junction cancer

VOLFI: FOLFOXIRI and panitumumab in RAS wild-type metastatic colorectal cancer

SPICE: Analysis of enadenotucirev plus nivolumab in metastatic colorectal cancer patients during the dose escalation phase

IMPALA results: Lefitolimod vs standard of care in metastatic colorectal cancer

AMG 510: A novel molecule targeting KRAS G12C mutant solid tumours

INVICTUS: Assessing the safety and efficacy of ripretinib in patients with advanced gastrointestinal stromal tumours

BEACON: Encorafenib plus cetuximab with or without binimetinib for BRAF V600E–mutant metastatic colorectal cancer

ATTRACTION-3: Nivolumab versus chemotherapy in advanced oesophageal squamous cell carcinoma

Advances in the treatment of peritoneal metastases in gastric cancer